Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01643 (Long intergenic non-protein coding RNA 1643) is a member of the long intergenic non-coding RNA (lincRNA) class, which comprises autonomously transcribed non-coding RNAs longer than 200 nucleotides that do not overlap with annotated protein-coding genes. LincRNAs are important epigenetic and transcriptional regulators, modulating chromatin structure, influencing gene expression, and potentially acting as molecular scaffolds or microRNA sponges, though direct biological functions for LINC01643 remain uncharacterized. It is not considered a classical therapeutic target, but represents part of a growing family of regulatory RNAs with emerging relevance in gene regulation and potentially disease association, pending further research
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1643 (LINC01643).